RE:I think people r over reacting ...You're missing the big picture. Their big revenue driver, IXINITY, is getting slashed big time. So much so they are materially cutting salesforce and efforts to sell it. That is not good at all. This means that revenues will continue to decline as will losses. The other drugs in their portfolio are nothing great so don't expect those to help. Management is a bunch of clowns clearly clueless on how to run a business. The only hope you have is approval of Treo but who knows if/when that will come and even if it;s approved, it will take some time for revenues to build. You can be talking 1-2 years from now if at all. No reason to own this stock when you know revenues will continue to decline, losses will pile up and there is no real catalyst coming near term.